Published in Dis Colon Rectum on April 01, 1996
Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition. J Med Genet (1999) 1.39
Surveillance and management of upper gastrointestinal disease in Familial Adenomatous Polyposis. Fam Cancer (2006) 1.11
Diagnosis and management of ampullary adenoma: The expanding role of endoscopy. World J Gastrointest Endosc (2011) 0.98
Desmoids in familial adenomatous polyposis are monoclonal proliferations. Br J Cancer (2000) 0.96
Transduodenal resection of peri-ampullary lesions. World J Surg (2005) 0.90
Recurrent desmoids determine outcome in patients with Gardner syndrome: a cohort study of three generations of an APC mutation-positive family across 30 years. Int J Colorectal Dis (2012) 0.90
Colorectal cancer: no longer the issue in familial adenomatous polyposis? Fam Cancer (2011) 0.88
Adenocarcinomas After Prophylactic Surgery For Familial Adenomatous Polyposis. J Cancer Ther (2013) 0.84
Cost comparison of predictive genetic testing versus conventional clinical screening for familial adenomatous polyposis. Gut (1999) 0.84
Familial adenomatous polyposis and desmoid tumors. Clinics (Sao Paulo) (2011) 0.83
FAP, gastric cancer, and genetic counseling featuring children and young adults: a family study and review. Fam Cancer (2010) 0.82
Hepatocellular adenoma associated with familial adenomatous polyposis coli. World J Hepatol (2012) 0.80
Inherited colorectal cancer syndromes. Clin Colon Rectal Surg (2009) 0.79
Ursodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial. Orphanet J Rare Dis (2013) 0.77
Duodenal adenoma surveillance in patients with familial adenomatous polyposis. World J Gastrointest Endosc (2015) 0.77
Duodenal mucosal risk markers in patients with familial adenomatous polyposis: effects of celecoxib/ursodeoxycholic acid co-treatment and comparison with patient controls. Orphanet J Rare Dis (2013) 0.76
Segmental resection with primary anastomosis is not always safe in splenic flexure perforation. BMC Res Notes (2016) 0.75
Gastrointestinal tract cancers: Genetics, heritability and germ line mutations. Oncol Lett (2017) 0.75
Cost-effectiveness of prophylactic surgery for duodenal cancer in familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev (2009) 0.75
A useful reconstruction arrangement following Whipple's resection for patients with familial adenomatous polyposis. Ann R Coll Surg Engl (2009) 0.75
An Unusual Case of Familial Adenomatous Polyposis Presenting with Gout and Jaundice. Cureus (2017) 0.75
Pancreas-sparing total duodenectomy for Spigelman stage IV duodenal polyposis associated with familial adenomatous polyposis: experience of 10 cases at a single institution. Fam Cancer (2017) 0.75
Prednisolone therapy for intra-abdominal desmoid tumors in a patient with familial adenomatous polyposis. J Gastroenterol (1997) 0.75
Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet (2001) 11.12
Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med (2000) 8.68
The molecular basis of Turcot's syndrome. N Engl J Med (1995) 6.65
MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell (1996) 4.13
Mismatch repair deficiency in phenotypically normal human cells. Science (1995) 3.55
Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet (2000) 3.52
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet (2004) 2.95
Cancer in an ileoanal reservoir: a new late complication? Gut (1990) 2.41
Genotype-phenotype correlations in attenuated adenomatous polyposis coli. Am J Hum Genet (1998) 2.12
Single-patient randomised clinical trial. Use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir. Lancet (1986) 2.06
Familial adenomatous polyposis-associated thyroid cancer: a clinical, pathological, and molecular genetics study. Am J Pathol (1999) 2.02
An unusual intraoperative complication of stapled colorectal anastomosis: report of a case and review of the literature. Can J Surg (1993) 2.00
Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma. Nature (2000) 1.93
Restorative proctocolectomy with ileal reservoir. Int J Colorectal Dis (1986) 1.91
Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology (1995) 1.90
Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol (1999) 1.85
Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res (1994) 1.85
Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res (2000) 1.81
Somatic instability of the APC I1307K allele in colorectal neoplasia. Cancer Res (1998) 1.79
Molecular biology of colorectal cancer. Curr Probl Cancer (1998) 1.70
Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res (1995) 1.69
Prospective evaluation of early morphological changes in pelvic ileal pouches. Gastroenterology (1994) 1.66
The ileal reservoir and ileoanal anastomosis procedure. Factors affecting technical and functional outcome. Dis Colon Rectum (1988) 1.64
Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res (1999) 1.62
COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer (2009) 1.62
Revising the troublesome stoma: combined abdominal wall recontouring and revision of stomas. Dis Colon Rectum (2003) 1.58
Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res (2000) 1.57
Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology (1991) 1.57
Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice. Cancer Res (2000) 1.56
Germline BRCA2 6174delT mutations in Ashkenazi Jewish pancreatic cancer patients. Nat Genet (1997) 1.55
Ontario familial colon cancer registry: methods and first-year response rates. Chronic Dis Can (2000) 1.55
Can the standard gamble be used to determine utilities for uncertain health states? An example using postoperative maintenance therapy in Crohn's disease. Med Decis Making (2000) 1.51
Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol (2003) 1.51
Pregnancy, delivery, and pouch function after ileal pouch-anal anastomosis for ulcerative colitis. Dis Colon Rectum (2002) 1.50
Functional outcome of conversion of ileorectal anastomosis to ileal pouch-anal anastomosis in patients with familial adenomatous polyposis and ulcerative colitis. Dis Colon Rectum (1999) 1.49
The pelvic pouch and ileoanal anastomosis procedure. Surgical technique and initial results. Am J Surg (1985) 1.47
Desmoid disease in patients with familial adenomatous polyposis. Dis Colon Rectum (2000) 1.47
Complications of loop ileostomy. Am J Surg (1987) 1.43
Radioimmunodetection of colorectal cancer metastases with 131I-labeled monoclonal antibody B72.3: a pilot study to determine efficacy of detection and pharmacokinetics. Cancer Invest (1993) 1.42
MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis. Cancer Res (1996) 1.41
Cytomegalovirus infection of the colon: a possible role in exacerbations of inflammatory bowel disease. Am J Gastroenterol (1985) 1.41
Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Fam Cancer (2007) 1.39
Unusual presentation of omphalomesenteric duct remnant: a variant of mesodiverticular band causing intestinal obstruction. J Pediatr Surg (2000) 1.39
Anal wall thickness under normal and inflammatory conditions of the anorectum as determined by endoluminal ultrasonography. Am J Gastroenterol (1995) 1.38
Double stapling technique for low anterior resection. Dis Colon Rectum (1983) 1.38
Cigarette smoking and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (Panc4). Ann Oncol (2011) 1.36
Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population. J Gastrointest Surg (2000) 1.35
Pancreatitis and pancreatic cancer risk: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2012) 1.35
Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice. Cancer Res (1996) 1.34
High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. J Immunol Methods (1994) 1.32
Hepatic resection of noncolorectal nonneuroendocrine metastases. Liver Transpl (2000) 1.32
Absence of linkage between inflammatory bowel disease and selected loci on chromosomes 3, 7, 12, and 16. Gastroenterology (1998) 1.32
Alcohol consumption and pancreatic cancer: a pooled analysis in the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.29
Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions. Clin Pharmacokinet (1995) 1.29
Reevaluation of nitrate and nitrite levels in the human intestine. Cancer Res (1981) 1.27
The double stapling technique for low anterior resection of rectal carcinoma. Dis Colon Rectum (1986) 1.27
Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet (1999) 1.26
Colorectal cancer survivors undergoing genetic testing for hereditary non-polyposis colorectal cancer: motivational factors and psychosocial functioning. Clin Genet (2007) 1.25
Risk factors for pelvic pouch failure. Dis Colon Rectum (1997) 1.25
Rare spontaneous regression of patent omphalomesenteric duct after birth. Arch Dis Child Fetal Neonatal Ed (2002) 1.23
The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Gut (2010) 1.23
Motivations and psychosocial impact of genetic testing for HNPCC. Am J Med Genet (2001) 1.20
Treatment of rectovaginal fistulas that has failed previous repair attempts. Dis Colon Rectum (1995) 1.18
Risk factors in elective laparoscopic cholecystectomy for conversion to open cholecystectomy. J Am Coll Surg (1994) 1.18
A cyclophilin-related protein involved in the function of natural killer cells. Proc Natl Acad Sci U S A (1993) 1.17
Preduodenal portal vein causing duodenal obstruction associated with situs inversus, intestinal malrotation, and polysplenia: A case report. J Pediatr Surg (2002) 1.17
Effect of mucous glycoprotein on nucleation time of human bile. Gastroenterology (1985) 1.16
Canine small bowel transplantation. A study of the immunological responses. Arch Surg (1976) 1.16
STK11/LKB1 germline mutations are not identified in most Peutz-Jeghers syndrome patients. Clin Genet (1999) 1.13
Microsatellite instability, mismatch repair deficiency, and colorectal cancer. Surgery (2001) 1.13
Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes. J Immunol (1994) 1.13
A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer (2010) 1.11
Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Hum Genet (1999) 1.10
Dysregulation of integrin-linked kinase (ILK) signaling in colonic polyposis. Oncogene (2001) 1.10
Cigar and pipe smoking, smokeless tobacco use and pancreatic cancer: an analysis from the International Pancreatic Cancer Case-Control Consortium (PanC4). Ann Oncol (2011) 1.10
Concerns of patients with inflammatory bowel disease: results from a clinical population. Am J Gastroenterol (2001) 1.08
Biosynthesis of eicosapentaenoic acid in the microalga Porphyridium cruentum. I: The use of externally supplied fatty acids. Lipids (1996) 1.07
Restorative proctocolectomy. Clinical results and manometric findings with long and short rectal cuffs. Dis Colon Rectum (1986) 1.07
Differential expression of sumatriptan-sensitive 5-hydroxytryptamine receptors in human trigeminal ganglia and cerebral blood vessels. Mol Pharmacol (1996) 1.07
The genetic basis of Muir-Torre syndrome includes the hMLH1 locus. Am J Hum Genet (1996) 1.07
Intra-rectal injection of tumour cells: a novel animal model of rectal cancer. Surg Oncol (1992) 1.06
Long-term results of anterior resection using the double-stapling technique. Dis Colon Rectum (1995) 1.05
Clinical correlates of bacteremia in a Veterans Administration extended care facility. J Am Geriatr Soc (1988) 1.05
Relapsing acute pancreatitis as the presenting manifestation of an ampullary neoplasm in a patient with familial polyposis coli. Am J Gastroenterol (1985) 1.04
Functional acetylcholine muscarinic receptor subtypes in human brain microcirculation: identification and cellular localization. J Cereb Blood Flow Metab (1999) 1.04